Benitec Biopharma, Inc. (BNTC)
12.72
+0.04
(+0.35%)
USD |
NASDAQ |
Sep 08, 16:00
12.73
0.00 (0.00%)
Pre-Market: 20:00
Benitec Biopharma Debt to Equity Ratio : 0.0048 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0048 |
| December 31, 2025 | 0.0053 |
| September 30, 2025 | 0.0087 |
| June 30, 2025 | 0.0087 |
| March 31, 2025 | 0.0098 |
| December 31, 2024 | 0.0018 |
| September 30, 2024 | 0.0033 |
| June 30, 2024 | 0.006 |
| March 31, 2024 | 0.0308 |
| December 31, 2023 | 0.0273 |
| September 30, 2023 | 0.022 |
| June 30, 2023 | 2.767 |
| March 31, 2023 | 0.1322 |
| December 31, 2022 | 0.0762 |
| September 30, 2022 | 0.0513 |
| June 30, 2022 | 0.2814 |
| March 31, 2022 | 0.1153 |
| December 31, 2021 | 0.0841 |
| September 30, 2021 | 0.0616 |
| June 30, 2021 | 0.0106 |
| March 31, 2021 | 0.024 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0213 |
| September 30, 2020 | 0.0464 |
| June 30, 2020 | |
| March 31, 2020 | 0.0365 |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 0.00 |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | 0.00 |
| June 30, 2016 | |
| March 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 187.00M |
| Total Liabilities (Quarterly) | 3.668M |
| Shareholders Equity (Quarterly) | 183.33M |
| Current Ratio | 56.82 |
| Net Debt Paydown Yield | -0.04% |